U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 3

1.
Figure 2

Figure 2. From: Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy.

Change of median visual acuity (logMAR) from baseline until the last examination.
Abbreviations: BCVA, best-corrected visual acuity; F–U, follow-up; m, months.

George D Tsakonas, et al. Clin Ophthalmol. 2012;6:1639-1644.
2.
Figure 3

Figure 3. From: Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy.

(A) Fundus autofluorescence of the case presented in , showing widespread and multiple areas of retinal pigment epithelium atrophies at baseline. (B) Twelve months after the photodynamic therapy treatment, no significant worsening of the atrophies is observed.

George D Tsakonas, et al. Clin Ophthalmol. 2012;6:1639-1644.
3.
Figure 1

Figure 1. From: Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy.

(A) Fluorescein angiography (FA) showing multiple areas of retinal pigment epithelium decompensation. The lines (B–D) correspond to the optical coherence tomography (OCT) scans with the same letter. OCT revealed foveal and perifoveal accumulation of subretinal and intraretinal fluid. The circles represent the area where the photodynamic therapy (PDT) spots where applied. The numbers indicate the order in which the PDT spots were performed. The FA (E) performed 12 months after the PDT session shows retinal pigment epithelium atrophies but not leakage. The OCT scans (F–H) performed on the same areas as the scans before treatment revealed no fluid.

George D Tsakonas, et al. Clin Ophthalmol. 2012;6:1639-1644.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center